Suppressive effects of electrolyzed reduced water on alloxan-induced apoptosis and type 1 diabetes mellitus.
Li Y, Hamasaki T, Nakamichi N, Kashiwagi T, Komatsu T, Ye J, Teruya K, Abe M, Yan H, Kinjo T, Kabayama S, Kawamura M, Shirahata S · Cytotechnology · 2011
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this animal study, supporting further research into its potential for type 1 diabetes.
Molecular hydrogen type 1 diabetes study 2011: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This animal study examined Suppressive effects of electrolyzed reduced water on alloxan-induced apoptosis (programmed cell death) and type 1 diabetes mellitus. The abstract describes Mouse model. Here, we showed that electrolyzed reduced water prevented alloxan-induced DNA fragmentation and the production of cells in sub-G1 phase in HIT-T15 pancreatic β-cells.
Publication: Li Y, Hamasaki T, Nakamichi N, Kashiwagi T, Komatsu T, Ye J, Teruya K, Abe M, Yan H, Kinjo T, Kabayama S, Kawamura M, Shirahata S, Cytotechnology, 2011.
What the researchers studied
The researchers examined how molecular hydrogen related to type 1 diabetes. The available structured record did not clearly identify one primary outcome, so the original source should be checked for the complete endpoint definitions.
What effects did molecular hydrogen have?
Observed hydrogen effects: Here, we showed that electrolyzed reduced water prevented alloxan-induced DNA fragmentation and the production of cells in sub-G1 phase in HIT-T15 pancreatic β-cells. Electrolyzed reduced water, which is capable of scavenging reactive oxygen species (ROS, chemically reactive molecules that can damage cells when excessive), is attracting recent attention because it has shown improved efficacy against several types of diseases including diabetes mellitus.
Why these findings matter
The result supports the biological and therapeutic potential of molecular hydrogen for type 1 diabetes. It shows that hydrogen affected meaningful outcomes in an animal model, but it does not prove that the same benefit will occur in people.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Mouse model
- Hydrogen method: Other or not reported
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.